Find out more about changes to NDSS products and services. Eligibility expansion for all people with type 1 diabetes to access subsidised CGM and Flash GM products through the NDSS Rollout commencing 1 July 2022 Access to subsidised continuous glucose monitoring (CGM) and flash glucose monitoring (Flash GM) products through the NDSS is expanding to include all people with type 1 diabetes. This means people with type 1 diabetes aged 21 years or older who do not have concessional status will have access to subsidised CGM and Flash GM products through the NDSS. Rollout of the expansion will commence on 1 July 2022. From this date, all people with type 1 diabetes will be able to apply for access. There are no changes for people with diabetes who currently access fully subsidised CGM or Flash GM products through the NDSS. Key information Access to subsidised continuous glucose monitoring (CGM) and flash glucose monitoring (Flash GM) products through the NDSS is expanding to include all people with type 1 diabetes. Rollout of the expansion will commence on 1 July 2022. For people who are now eligible and registered with the NDSS, there are different processes to start accessing subsidised products. For most people, there are a few steps you will need to take. The exact date you can start purchasing subsidised products will depend on the pathway relevant to you. Once your eligibility is confirmed, you will receive notification from the NDSS confirming access and you will be able to start purchasing subsidised products through NDSS Access Points (usually a community pharmacy). For people with type 1 diabetes aged 21 years or older who do not have concessional status, the co-payment you will pay is equivalent to $32.50 per one month’s supply. Find out more about the eligibility expansion for all people with type 1 diabetes, including helpful FAQs, and how to apply for access from 1 July 2022. Previous important announcements Changes from 1 July 2022: Eligibility expansion for all people with type 1 diabetes to access subsidised CGM and Flash GM products through the NDSS Changes from 30 May 2022: FreeStyle Libre sensors—DELISTING Changes from 1 March 2022: Dexcom G5 Mobile Changes from 1 August 2021: FreeStyle Libre 2 Changes from 18 January 2021: Dexcom G6, Medtronic and authorised certifiers Changes from 1 March 2020: FreeStyle Libre added and eligibility criteria streamlined Government funding boost enables more people to access new glucose monitoring devices through the NDSS from 1 March 2019 Related resources NDSS News Changes to the NDSS for health professionals Changes to the NDSS for Access Points
